GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2008 (Vol. 28, No. 1)

  • Extensive database
  • Hard to get a handle on the contents
Aimed at the legion of people interested in designing new drugs, KiBank is a basic site focused on helping researchers towards this end. The site’s approach to the subject is by providing structures (chemicals and target proteins), binding affinity information, and a handful of selected links. With over 16,000 entries relating to binding affinity, the site has no shortage of information. The searching scheme employed allows users to find information by chemical name, by protein name, or by protein function. The last two options are interconnected and options within them can be combined to allow visitors to browse through information about proteins in various categories. Overall, I didn’t get a sense of the breadth of the site, perhaps because to do so would require many more searches than this review would allow. Perhaps the designers should consider better descriptions of the content and other options for searching the database.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »